Nature Genetics is a premier journal in the field of genetics published by NATURE PORTFOLIO, renowned for its impactful research and significant contributions to the understanding of genetic mechanisms and their implications for human health. Since its establishment in 1992, the journal has continually maintained a strong reputation, evidenced by its impressive Q1 ranking in the Genetics category and a commendable Scopus ranking of #4 out of 347 in Genetics, placing it in the 98th percentile. Although it does not currently offer Open Access options, Nature Genetics remains a critical resource for researchers and practitioners, providing cutting-edge studies and papers that drive advancements in both fundamental and applied genetic research. With a global readership and contributions from leading scientists around the world, this journal is a vital platform for disseminating innovative findings and fostering discussions at the frontier of genetics.

MUTAGENESIS, published by Oxford University Press, is a leading journal in the fields of genetics, toxicology, and health, dedicated to advancing our understanding of mutagenic processes and their implications for human health. With an ISSN of 0267-8357 and an E-ISSN of 1464-3804, this journal has been at the forefront of mutagenesis research since its inception in 1986 and will continue to publish cutting-edge studies until 2024. Holding an impressive position in the academic community, MUTAGENESIS is ranked Q2 in Genetics, Q2 in Clinical Genetics, Q2 in Health, Toxicology, and Mutagenesis, and Q1 in Toxicology, reflecting its commitment to high-quality scholarly work. The journal enjoys a robust global readership, with significant rankings in various Scopus categories, including top positions in Environmental Science and Clinical Genetics, ensuring that it remains a vital resource for researchers, professionals, and students alike. While access to its articles is not completely open, MUTAGENESIS provides valuable insights that fuel innovative research and drive forward the understanding of genetic risks and toxicological assessments.

HUMAN HEREDITY is a peer-reviewed journal published by KARGER, dedicated to advancing the understanding of genetics and inherited traits in human populations. Established in 1950, this journal has become a vital resource for researchers, professionals, and students in the fields of genetics and clinical genetics, currently categorized in the third quartile (Q3) for both general and clinical genetics as of 2023. With an ISSN of 0001-5652, HUMAN HEREDITY provides rigorous academic content that analyzes heredity patterns and genetic variations, aiming to illuminate the complexities of human genetic inheritance. Although it does not operate on an open access model, the journal offers a comprehensive collection of studies and insights that are crucial for genetic research and clinical applications. Situated in Basel, Switzerland, HUMAN HEREDITY contributes to the global dialogue in genetics, making it an essential platform for those seeking to enrich their understanding of human heredity in a rapidly evolving scientific landscape.

GENETIC EPIDEMIOLOGY is a pioneering journal published by Wiley that bridges the fields of genetics and epidemiology to advance our understanding of the genetic underpinnings of health and disease. Established in 1984 and converging into its 40th year of impactful research in 2024, this journal offers a key platform for the dissemination of innovative research findings, statistical methods, and applications in both clinical genetics and epidemiological practices. With a robust presence in Scopus, ranking in the second quartile (Q2) for both epidemiology and clinical genetics, it enjoys a significant reputation among its peers. The journal does not currently offer open access, but it is vital for researchers, professionals, and students committed to exploring the evolving landscape of genetic influences on population health. Its rich repository of studies not only enhances knowledge but also informs public health policies and clinical practices worldwide, making it an indispensable resource for those seeking to innovate and apply genetic research in the quest for better health outcomes.

HUMAN GENETICS, published by SPRINGER, stands as a cornerstone journal in the field of genetics, offering a wealth of research insights since its inception in 1964. Hailing from Germany, this esteemed journal boasts an impressive Q1 ranking in both Genetics and Clinical Genetics, marking it among the top quartile of journals in these categories for 2023. With a notable Scopus rank of #7 in Clinical Genetics and a percentile ranking of 93, HUMAN GENETICS attracts significant attention from researchers and professionals dedicated to advancing our understanding of genetic influences on human health and disease. Although it does not currently offer Open Access options, the journal provides a critical platform for scholarly communication, aimed at disseminating groundbreaking findings in genetics and biotechnology. As the field evolves, HUMAN GENETICS continues to play an instrumental role in bridging the gap between laboratory research and clinical application, making it an essential resource for students and seasoned researchers alike.

Human Genomics, published by BMC, is a leading open-access journal dedicated to advancing the field of genomics and its applications in health and disease. Since its inception in 2003, the journal has provided a vital platform for researchers to disseminate groundbreaking findings related to genetic research, contributing significantly to areas such as Drug Discovery, Genetics, Molecular Biology, and Molecular Medicine, as reflected in its Q1 and Q2 quartile rankings throughout 2023. With an ISSN of 1473-9542 and an E-ISSN of 1479-7364, Human Genomics not only delivers high-quality, peer-reviewed research but also ensures accessibility to a broader audience, empowering professionals, students, and academics to stay at the forefront of genomic science. Through its rigorous editorial standards and impactful publications, the journal fosters a collaborative environment for innovative research across the globe from its base in the United Kingdom. By promoting open access since its launch, Human Genomics continues to enhance the visibility and impact of genetic studies, making it an essential resource for anyone involved in the rapidly evolving field of human genomics.

Genes and Nutrition is a prominent open access journal published by BMC in the United Kingdom, dedicated to advancing knowledge at the intersection of nutrition, genetics, and human health. With the aim of making cutting-edge research available to a global audience, the journal has been a vital platform for sharing discoveries since its inception in 2007, and it continues to thrive with a convergence period extending to 2024. Recognized for its high-quality contributions, Genes and Nutrition is rated in the Q2 category within both Endocrinology, Diabetes, and Metabolism and Genetics as of 2023, reflecting its esteemed position in these fields (Scopus Ranks leaderboard places it at #72/244 and #109/347, respectively). This journal is an invaluable resource for researchers, professionals, and students alike, fostering collaboration and innovation in the understanding of how genetic factors influence nutrition and health outcomes. Accessible to all since 2016, it encourages dialogue and discovery, positioning itself as a leader in genetic and nutritional science.

HEREDITY is a prestigious academic journal published by SpringerNature, specializing in the dynamic fields of Genetics and Genetics (Clinical). With a history of excellence since its inception in 1947, this journal has established itself as a significant contributor to the understanding of genetic research, addressing both foundational principles and clinical applications. Operating without an open access model, it maintains a strong reputation with an impact factor that reflects its rigorous peer-review process and high-quality submissions, ranking in the top quartiles of its category as evidenced by its Q2 classification in Genetics and Genetics (clinical) for 2023. Further, HEREDITY holds commendable positions in Scopus rankings, illustrating its influence within the field, currently placed #21 out of 99 in Medicine (Clinical Genetics) and #87 out of 347 in Biochemistry, Genetics, and Molecular Biology (Genetics). Researchers, professionals, and students are invited to explore the latest discoveries and advancements in genetics through this esteemed journal, contributing to the broader discourse and innovation within the field.

American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, published by Wiley, stands at the forefront of research dedicated to the intricate relationship between genetics and neuropsychiatric disorders. With an impressive scope that bridges various disciplines, this journal serves as a premier platform for groundbreaking studies and innovative perspectives in the fields of Cellular and Molecular Neuroscience, Genetics, and Psychiatry and Mental Health. Featuring a robust impact factor and categorized in the Q1 and Q2 quartiles across multiple relevant categories, the journal has successfully positioned itself as a leading source of high-quality research, ranking 52nd in Cellular and Molecular Neuroscience, 37th in Clinical Genetics, and 157th in Psychiatry and Mental Health within Scopus. Since its inception in 1995, it has sustained a commitment to fostering scholarly excellence and advancing our understanding of the genetic underpinnings of mental health. The journal is poised to continue its mission until 2024 and offers open access options, facilitating wider dissemination of vital knowledge among researchers, healthcare professionals, and students alike.

Frontiers in Genetics is a premier academic journal dedicated to advancing the field of genetics through high-quality, peer-reviewed research. Published by FRONTIERS MEDIA SA in Switzerland since 2010, this Open Access journal provides a platform for researchers and practitioners to disseminate innovative findings across various subfields, including clinical genetics and molecular medicine. With a notable emphasis on interdisciplinary approaches, the journal holds a strong position in the academic landscape, achieving Q2 rankings in key categories such as Genetics and Molecular Medicine in 2023. Not only does Frontiers in Genetics contribute to the scholarly dialogue by publishing impactful studies, but it also promotes accessibility to vital research, ensuring that knowledge is available to a global audience. This journal is a vital resource for researchers, professionals, and students looking to stay at the forefront of genetic discoveries and their applications, reflective of its engagement with contemporary challenges in genetics and healthcare.